ATCC 25285 脆弱擬桿菌

ATCC 25285 脆弱擬桿菌

ATCC® Number:   25285™

Preceptrol® Culture

Organism:  Bacteroides fragilis （Veillon and Zuber） Caslani and Chalmers

Designations:  V

History:  ATCC <<--WE Moore<<--A. SonnenwiPI 2553 [EN-2; NCTC 9343]

Isolation:  Appendix abscess

Depositor:  WE

Shipped:  freeze-dried  Moore  rth EN-2 <<--- NCTC 9343 <<--- L. Garrod

Biosafety Level:  2

Growth Conditions:  ATCC medium1490: Modified chopped meat medium

Temperature: 37.0°C

Duration: anaerobic

Permits/Forms:  In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

Cross References:  Nucleotide （GenBank） : AF280705 Bacteroides fragilis isolate ATCC 25285 RecA （recA） gene, partial cds.

Nucleotide （GenBank） : AX110196 Sequence 929 from Patent WO0123604.

Nucleotide （GenBank） : X83935 B.fragilis 16S rRNA （ATCC 25285T）.

Nucleotide （GenBank） : CR626927Bacteroides fragilis NCTC 9343, complete genome.

Nucleotide （GenBank） : AF280642 Bacteroides fragilis isolate ATCC 25285 glutamine synthetase （glnA） gene, partial cds.

Nucleotide （GenBank） : U05887 Bacteroides fragilis ATCC 25285 beta-lactamase （cepA-85） gene, complete cds.

Type Strain:  yes（type strain）

Comments:  Genome sequenced strain

Applications:  media testing [92430] [21529]

quality control [92216]

quality control strain [92125] [92162] [92152]

susceptibility testing [21527]

quality control strain for BBL and MicroScan [Reg TM] products

Related Products:  purified DNA:ATCC 25285D

ATCC 25285 脆弱擬桿菌

References:  6005: Cato EP, Johnson JL. Reinstatement of species rank for Bacteroides fragilis, B. ovatus, B. distasonis, B. thetaiotaomicron, and B. vulgatus: Designation of neotype strains for Bacteroides fragilis （Veillon and Zuber） Caslani and Chalmers and Bacteroides thetaiotaomicron （Distaso） Caslani and Chalmers. Int. J. Syst. Bacteriol. 26: 230-237, 1976.

21527: CLSI Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M11-A7.

21529: CLSI Quality Control for Commercially Prepared Microbiological Culture Media; Approved Standard - 3rd Edition. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M22-A3.

36887: Skerman VB, et al. Approved lists of bacterial names. Int. J. Syst. Bacteriol. 30: 225-420, 1980.

39924: Takahata M, Nishino T. Antibacterial activities of tosufloxacin against anaerobic bacteria and the electron micrograph of its bactericidal effects. Chemotherapy 43: 153-158, 1997. PubMed: 9142454

92125: BD Crystal ANR. :BD Becton Dickinson;Crystal

92152: MicroScan Rapid Anaerobic Panel. :Dade Behring;MicroScan

92162: Sensititre Anaerobe MIC Susceptibility. :Trek Diagnostic Systems;Sensititre

92216: CLSI Quality Control of Microbiological Transport Systems; Approved Standard. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M40-A.

92430: Medical microbiology--Culture media -- Part 4: Transport systems for specimens containing bacteria. Berlin, Germany:Deutsches Institut fur Normung;DIN DIN 58942-4: 2003, 2003